CRNT
Ceragon Networks Ltd.
CRNT has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CRNT overall, supported by stronger fundamentals and stronger modeled upside.
CRNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CRNT's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CRNT PE Valuation
CRNT has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CRNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CRNT, with profitability improving. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CRNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.14 | — |
| Q2 2026 | -$0.04 | -125% |
| Q1 2026 | -$0.03 | -112% |
| Q4 2025 | -$0.02 | -107% |
| Q3 2025 | $0.02 | -91% |
| Q2 2025 | $0.16 | +33% |
| Q1 2025 | $0.26 | +420% |
| Q4 2024 | $0.27 | +286% |
| Q3 2024 | $0.22 | +340% |
CRNT has swung to a loss: it lost $0.04 per share over the past year, after a profit the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CRNT in the latest year-over-year earnings comparison.
CRNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $93.9M | +14% |
| Q1 2026 | $85M | -4.1% |
| Q4 2025 | $82.3M | -23% |
| Q3 2025 | $85.5M | -17% |
| Q2 2025 | $82.3M | -14% |
| Q1 2025 | $88.7M | +0.2% |
| Q4 2024 | $106.9M | +18% |
| Q3 2024 | $102.7M | +18% |
CRNT's revenue is down over the past year, though its latest quarter was up: $94M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.3% | -2.7 points |
| Q1 2026 | 2.5% | +3.7 points |
| Q4 2025 | 2.1% | -6.8 points |
| Q3 2025 | 4.4% | -9.9 points |
| Q2 2025 | 3% | -7.8 points |
| Q1 2025 | -1.2% | -6 points |
| Q4 2024 | 8.9% | +4.3 points |
| Q3 2024 | 14% | +6.6 points |
CRNT's operating margin was 0.3% last quarter, down 2.7 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CRNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CRNT on profitability, with a higher operating margin.
CRNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.7M | -69% |
| Q1 2026 | $2.8M | +$4.2M |
| Q4 2025 | $8.6M | +$11.9M |
| Q3 2025 | $4.4M | -58% |
| Q2 2025 | $5.6M | +$6M |
| Q1 2025 | -$1.4M | -150% |
| Q4 2024 | -$3.2M | -142% |
| Q3 2024 | $10.6M | -2.6% |
CRNT generated $18M in free cash flow over the past year, up 52% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over CRNT on cash flow, with more consistent year-over-year improvement.
CRNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | 0.2x | Very low |
CRNT has more cash than debt.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CRNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.9 | Neutral |
| Stochastic | 59.2 | Neutral |
CRNT's weekly RSI is 57 (neutral) and its Stochastic is 59 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CRNT PE vs Technology Sector
| Metric | CRNT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CRNT has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CRNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.15 | 11% above |
| 20 week MA | $2.16 | 10% above |
| 50 week MA | $2.29 | 3.9% above |
| 100 week MA | $2.50 | 4.8% below |
| 200 week MA | $2.44 | 2.5% below |
CRNT has stronger trend alignment. CRNT is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CRNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.06 | $2.86 | +39% |
| 2021 | $2.86 | $2.64 | -7.7% |
| 2022 | $2.64 | $1.90 | -28% |
| 2023 | $1.90 | $2.16 | +14% |
| 2024 | $2.16 | $4.71 | +118% |
| 2025 | $4.71 | $2.11 | -55% |
| 2026 YTD | $2.11 | $2.38 | +13% |
CRNT's yearly returns have swung widely, from +118% in 2024 to −55% in 2025. It's up 13% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CRNT on returns for 2026, with the stronger performance.